Process View
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of fibroblast migration"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.991 | ||
| ENG | endoglin | 0.988 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.985 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.982 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.968 | ||
| THBS1 | thrombospondin 1 | 0.928 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.895 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.875 | ||
| S100B | S100 calcium binding protein B | 0.847 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.793 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.769 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.703 | ||
| APP | amyloid beta (A4) precursor protein | 0.626 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.541 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.444 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.434 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.415 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.412 | ||
| BGN | biglycan | 0.397 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.393 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.381 | ||
| COL11A2 | collagen, type XI, alpha 2 | 0.351 | ||
| FAP | fibroblast activation protein, alpha | 0.275 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.269 | ||
| INHBA | inhibin, beta A | 0.253 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.250 | Human | |
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.229 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.193 | ||
| FSTL1 | follistatin-like 1 | 0.183 | ||
| FN1 | fibronectin 1 | 0.172 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.164 | ||
| DOK1 | docking protein 1, 62kDa (downstream of tyrosine kinase 1) | 0.159 | ||
| SH2D1A | SH2 domain containing 1A | 0.158 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.135 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.133 | ||
| GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.130 | ||
| TMEM108 | transmembrane protein 108 | 0.128 | ||
| TTR | transthyretin | 0.123 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.122 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.119 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.113 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.108 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.105 | ||
| CALD1 | caldesmon 1 | 0.104 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.100 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.097 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.077 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.076 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.075 | ||
| LOX | lysyl oxidase | 0.075 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.071 | ||
| THY1 | Thy-1 cell surface antigen | 0.071 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.066 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.065 | ||
| CTGF | connective tissue growth factor | 0.062 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.060 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.059 | ||
| RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.055 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.054 | Human | |
| OSMR | oncostatin M receptor | 0.053 | ||
| LAMB1 | laminin, beta 1 | 0.053 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.052 | ||
| AEBP1 | AE binding protein 1 | 0.051 | ||
| VEGFC | vascular endothelial growth factor C | 0.051 | ||
| TNC | tenascin C | 0.050 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.048 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.047 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.046 | ||
| PLAU | plasminogen activator, urokinase | 0.044 | ||
| GREM1 | gremlin 1 | 0.044 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.041 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.041 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.040 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.040 | ||
| EDNRA | endothelin receptor type A | 0.039 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.038 | ||
| FBN1 | fibrillin 1 | 0.037 | ||
| S100A1 | S100 calcium binding protein A1 | 0.036 | ||
| COL11A1 | collagen, type XI, alpha 1 | 0.036 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.036 | ||
| RHOU | ras homolog gene family, member U | 0.035 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.034 | ||
| CD84 | CD84 molecule | 0.033 | ||
| FBLN2 | fibulin 2 | 0.033 | ||
| SULF1 | sulfatase 1 | 0.031 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.031 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.031 | ||
| FLNA | filamin A, alpha | 0.030 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.030 | ||
| PARVA | parvin, alpha | 0.030 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.030 | ||
| PRKCA | protein kinase C, alpha | 0.029 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.028 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.028 | ||
| ACVR2B | activin A receptor, type IIB | 0.026 | ||
| TLN1 | talin 1 | 0.026 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.025 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.025 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.025 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.024 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.024 | ||
| PRRX1 | paired related homeobox 1 | 0.023 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.022 | ||
| NRP1 | neuropilin 1 | 0.022 | ||
| FKBP10 | FK506 binding protein 10, 65 kDa | 0.021 | ||
| NRP2 | neuropilin 2 | 0.021 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.021 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.021 | ||
| NNMT | nicotinamide N-methyltransferase | 0.021 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.021 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.020 | ||
| CD244 | CD244 molecule, natural killer cell receptor 2B4 | 0.020 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.020 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.020 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.020 | ||
| LTBP1 | latent transforming growth factor beta binding protein 1 | 0.020 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.020 | ||
| SPHK1 | sphingosine kinase 1 | 0.020 | ||
| LIMK1 | LIM domain kinase 1 | 0.019 | ||
| DCN | decorin | 0.019 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.019 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.019 | ||
| THBS2 | thrombospondin 2 | 0.019 | Human | |
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.019 | ||
| ITGBL1 | integrin, beta-like 1 (with EGF-like repeat domains) | 0.019 | ||
| PDPN | podoplanin | 0.018 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.018 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.018 | ||
| MRC2 | mannose receptor, C type 2 | 0.017 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.016 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.016 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.016 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.016 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.015 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.015 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.015 | ||
| OLFML2B | olfactomedin-like 2B | 0.015 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.015 | ||
| NTM | neurotrimin | 0.015 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.015 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.014 | ||
| ILK | integrin-linked kinase | 0.014 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.014 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.014 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.014 | ||
| POSTN | periostin, osteoblast specific factor | 0.014 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.014 | ||
| EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0.014 | ||
| NID1 | nidogen 1 | 0.014 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.014 | ||
| FNDC1 | fibronectin type III domain containing 1 | 0.014 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.014 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.014 | ||
| FMOD | fibromodulin | 0.014 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.013 | ||
| EMILIN1 | elastin microfibril interfacer 1 | 0.013 | ||
| TAGLN | transgelin | 0.013 | ||
| RAI14 | retinoic acid induced 14 | 0.013 | ||
| KRT18 | keratin 18 | 0.013 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.013 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.013 | ||
| BMP1 | bone morphogenetic protein 1 | 0.012 | ||
| MAP1B | microtubule-associated protein 1B | 0.012 | ||
| S100P | S100 calcium binding protein P | 0.012 | ||
| COL8A2 | collagen, type VIII, alpha 2 | 0.012 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.012 | ||
| PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 | 0.012 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.012 | ||
| A2M | alpha-2-macroglobulin | 0.012 | ||
| SDC2 | syndecan 2 | 0.012 | ||
| ASPN | asporin | 0.011 | ||
| THBS4 | thrombospondin 4 | 0.011 | Human | |
| SLIT2 | slit homolog 2 (Drosophila) | 0.011 | ||
| ANGPT1 | angiopoietin 1 | 0.011 | ||
| SEC16A | SEC16 homolog A (S. cerevisiae) | 0.011 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.011 | ||
| VCAN | versican | 0.011 | ||
| PLXDC1 | plexin domain containing 1 | 0.011 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.011 | ||
| STC1 | stanniocalcin 1 | 0.011 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.011 | ||
| COL12A1 | collagen, type XII, alpha 1 | 0.011 | ||
| LOXL1 | lysyl oxidase-like 1 | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| COMP | cartilage oligomeric matrix protein | 0.011 | Human | |
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.010 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.010 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.010 | ||
| CTSK | cathepsin K | 0.010 | ||
| TPST1 | tyrosylprotein sulfotransferase 1 | 0.010 | ||
| SNAI2 | snail homolog 2 (Drosophila) | 0.010 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.010 | ||
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.010 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.010 | ||
| TPM2 | tropomyosin 2 (beta) | 0.010 |